An important alliance to accelerate the development of Safe in the Spanish market
Fleurieux-sur-l’Arbresle – France – December 17, 2025 – Safe (FR001400ZU25 – ALSAF) announces the signing of an exclusive distribution agreement with Vortrom Biologics, a subsidiary of Vortrom, for the Spanish market.
A strategic partnership with a leading player
For more than 40 years, Vortrom, an important distributor of medical equipment in Spain, is now named exclusive partner of the Safe Group for the distribution of its surgical solutions throughout Spain. This strategic alliance is part of Safe’s commitment to accelerate its international expansion and strengthen its presence in key European markets by offering increasingly innovative solutions that meet the highest standards, improve surgical techniques, facilitate patient recovery and reduce the cost of procedures.
Thanks to its extensive distribution network, its recognized experience in the orthopedic sector and its deep knowledge of the Spanish market, Vortrom Biologics has the assets to guarantee the optimal deployment of safe solutions in healthcare centers and among spine surgery professionals.
An important growth opportunity
Spain is a strategic market for Safe, with more than 47 million inhabitants and a modern health system that offers significant growth potential. This partnership will allow Safe to leverage Vortrom’s commercial strength and credibility to effectively penetrate this market.
Philippe Laurito, CEO of Safe Group, said: “We are very proud to partner with Vortrom, a major and respected player in the Spanish market. This agreement demonstrates the attractiveness of our innovative solutions and our ability to forge strategic partnerships with leading distributors. Vortrom’s experience and established network will allow us to significantly accelerate our development in Spain.”
Lucía Muñoz, CEO of Vortrom Biologics, stated: “We are delighted to add Safe’s innovative solutions to our portfolio. These technologies perfectly meet the needs of Spanish surgeons and are in line with our strategy of offering our clients the most advanced solutions on the market.”
About the secure group
Safe Group is a French medical technology group that brings together Safe Orthopedics, a pioneer in turnkey technologies for spinal pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgeries. The group employs approximately 100 people.
Safe Orthopedics develops and manufactures kits that combine sterile implants and ready-to-use instruments, available at any time to the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, for the benefit of the patient and with a positive impact on hospitalization times and costs. Protected by 15 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopedics has subsidiaries in the United Kingdom, Germany and the United States.
For more information: www.safeorthopedics.com
Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production centers in France and Tunisia, which offer numerous industrial services: industrialization, machining, finishing and sterile packaging.
For more information: www.safemedical.fr
Contact
AELYON ADVISORS OF THE SEGURO GROUP
investors@safeorthopaedics.com safe@aelyonadvisors.fr
Attach
